Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia.
BACKGROUND
To evaluate the clinical validity of genome-wide oligonucleotide array comparative genomic hybridization (aCGH) for detecting somatic abnormalities, we have applied this genomic analysis to 30 cases (13 MDS and 17 AML) with clonal chromosomal abnormalities detected in more than 50% of analyzed metaphase cells.


RESULTS
The aCGH detected all numerical chromosomal gains and losses from the mainline clones and 113 copy number alterations (CNAs) ranging from 0.257 to 102.519 megabases (Mb). Clinically significant recurrent deletions of 5q (involving the RPS14 gene), 12p12.3 (ETV6 gene), 17p13 (TP53 gene), 17q11.2 (NF1 gene) and 20q, double minutes containing the MYC gene and segmental amplification involving the MLL gene were further characterized with defined breakpoints and gene contents. Genomic features of microdeletions at 17q11.2 were confirmed by FISH using targeted BAC clones. The aCGH also defined break points in a derivative chromosome 6, der(6)t(3;6)(q21.3;p22.2), and an isodicentric X chromosome. However, chromosomally observed sideline clonal abnormalities in five cases were not detected by aCGH.


CONCLUSIONS
Our data indicated that an integrated cytogenomic analysis will be a better diagnostic scheme to delineate genomic contents of chromosomal and cryptic abnormalities in patients with MDS and AML. An evidence-based approach to interpret somatic genomic findings was proposed.
Molecular Cytogenetics Laboratory, Department of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, USA. peining.li@yale.edu.
Renu
R
Bajaj
Fang
F
Xu
Bixia
B
Xiang
Katherine
K
Wilcox
Autumn J
AJ
Diadamo
Rachana
R
Kumar
Alexandra
A
Pietraszkiewicz
Stephanie
S
Halene
Peining
P
Li
N Engl J Med. 1999 Sep 30;341(14):1051-62
10502596
Blood. 2009 Feb 19;113(8):1741-8
19109227
Mol Cytogenet. 2010 Nov 15;3:23
21078186
Haematologica. 2009 Feb;94(2):213-23
19144660
Am J Clin Pathol. 2008 Nov;130(5):818-23
18854276
Biochem Biophys Res Commun. 2009 May 29;383(2):245-51
19358830
Blood. 2008 Oct 15;112(8):3412-24
18663149
Cancer Genet Cytogenet. 2008 Jun;183(2):117-20
18503831
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12950-5
19651600
Genes Chromosomes Cancer. 2006 Mar;45(3):257-64
16283618
Genes Chromosomes Cancer. 2009 Jun;48(6):510-20
19306356
J Clin Oncol. 2007 Aug 10;25(23):3503-10
17687155
J Clin Oncol. 2006 Aug 20;24(24):3887-94
16864856
PLoS One. 2009;4(2):e4583
19240791
Am J Med Genet A. 2008 Aug 1;146A(15):1942-54
18627053
Nature. 2008 Jan 17;451(7176):335-9
18202658
Nat Med. 2010 Jan;16(1):49-58
19898489
Cell Cycle. 2010 Mar 1;9(5):855-6
20160505
Am J Med Genet C Semin Med Genet. 2009 Aug 15;151C(3):235-40
19621463
Leukemia. 2007 Jun;21(6):1224-31
17377590
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12944-9
19651601
Leukemia. 2007 Mar;21(3):571-4
17268525
J Mol Diagn. 2010 Mar;12(2):204-12
20093387
Leukemia. 2010 May;24(5):1065-9
20164853
J Mol Diagn. 2009 Nov;11(6):524-9
19767589
Leuk Res. 2007 May;31(5):605-9
16996130
Cancer Genet Cytogenet. 2008 Dec;187(2):101-11
19027491
Genes Chromosomes Cancer. 2007 Dec;46(12):1119-28
17823930
Blood. 1997 Mar 15;89(6):2079-88
9058730
Br J Haematol. 2004 Aug;126(4):495-500
15287941
Pediatr Neurol. 2009 Dec;41(6):391-8
19931159